|
|
||||||||


Department of Paediatrics, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada
Correspondence
David P. Speert
dspeert{at}cw.bc.ca
| ABSTRACT |
|---|
|
|
|---|
Present address: Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Present address: Research Institute, Rm 377, 950 West 28th Avenue, Vancouver, BC V5Z 4H4, Canada
| INTRODUCTION |
|---|
|
|
|---|
Mechanisms of BCC virulence have been demonstrated by its invasion of eukaryotic cells and acute inflammation culminating in death in murine models of infection (Chu et al., 2002
; Martin & Mohr, 2000
; Schwab et al., 2002
; Sokol et al., 2003
; Urban et al., 2004
). Several putative virulence factors have also been identified in the BCC, including a type III secretion system, cable pilus, siderophores and haemolysin (Hutchison et al., 1998
; Sajjan et al., 1995
; Tomich et al., 2003
; Visser et al., 2004
). The role of these factors in human disease has not yet been demonstrated, and their expression is variable among CF isolates of B. cenocepacia. Despite such variability, previous studies have differentiated B. cenocepacia isolates from other BCC species, such as Burkholderia multivorans, by their differential virulence in patients with CF (Aris et al., 2001
; Mahenthiralingam et al., 2001
). Furthermore, different species in the BCC demonstrate distinct patterns of virulence in a murine model of pulmonary infection (Chu et al., 2002
). In this model, B. multivorans persists in the lung of immunosuppressed BALB/c mice for up to 16 days without causing illness whereas B. cenocepacia is rapidly cleared but induces a pronounced host response that results in substantial toxicity and death in some animals. These results demonstrate pathogenic differences among species and prompted us to investigate bacterial determinants of virulence in these important CF pulmonary pathogens.
We previously reported B. cenocepacia adaptation to a murine host after sequential passages of a clinical strain in a pulmonary infection model (Chung et al., 2003
). The parent B. cenocepacia strain is rapidly cleared from the murine lung whereas the passaged strain variant persists. Comparative analyses between these two clonal isolates identified a colonial morphology change, increased piliation and enhanced exopolysaccharide (EPS) production as potential factors for persistence in vivo. Our observations highlighted a potential role for colonial morphology in differentiating B. cenocepacia strains, particularly those that cause persistent rather than transient infections. Further analyses of these colonial variants were undertaken to identify the protein differences responsible for such diverse infection outcomes. In the current study we present differences in alkyl hydroperoxide reductase subunit C (AhpC) and flagellin expression as detected by two-dimensional (2D) gel electrophoresis. Our observations on differential expression of potential virulence determinants between these two strain variants form the basis of this report.
| METHODS |
|---|
|
|
|---|
Extraction of inner- and outer-membrane proteins.
Membrane proteins were isolated by modification of the method of Hancock & Nikaido (1978)
. Four hundred millilitre bacterial cultures were grown shaking in LB broth. Bacteria were centrifuged at 7000 g for 15 min at 4 °C and resuspended in 6 ml cold 10 mM Tris/HCl (pH 8) containing 20 % (w/v) sucrose. Suspensions were frozen at 20 °C and thawed to assist cell breakage, treated with 50 µg DNase (Roche) ml1 and passed twice through a French pressure cell at 69 MPa. Unbroken cells were removed by centrifugation at 1000 g for 10 min at 4 °C. Four millilitres of the supernatant [in 20 % (w/v) sucrose] was layered onto a two-step sucrose density gradient containing 4 ml of 70 % (w/v) sucrose and 4 ml of 50 % (w/v) sucrose. Samples were centrifuged without braking at 100 000 g in an SW41 rotor overnight at 4 °C. The inner-membrane (IM) fraction lay between the 20 and 50 % sucrose layers while the outer-membrane (OM) fraction was between the 50 and 70 % sucrose layers. The fractions were collected separately, diluted in two to three volumes of distilled water, centrifuged at 17 000 g for 1 h, and resuspended in 100 µl distilled water. Proteins were quantified using the Bradford and Lowry assay. Approximately 15 µg protein was mixed with Laemmli buffer, boiled, electrophoresed on SDS-12.5 % PAGE gels then stained with 0.02 % (w/v) Coomassie brilliant blue in 25 % (v/v) ethanol and 10 % (v/v) acetic acid.
Whole-cell protein extractions.
Bacteria were grown at 37 °C or 42 °C in 100 ml LB broth. Bacteria were centrifuged at 4500 g at 4 °C, washed once with cold PBS then resuspended in 1 ml cold lysis buffer [5 mM EDTA and 1 mM PMSF (Sigma) in PBS]. This suspension was added to 500 µl washed glass beads (0.1 mm diameter) in a 2 ml tube. Cells were lysed with a mini bead-beater (Biospec Products) for three pulses of 1 min with 20 s intervals on ice to prevent overheating. Lysates were centrifuged at 14 000 g for 3 min at 4 °C, and the supernatant was collected. The pellet was resuspended in 1 ml lysis buffer, disrupted by bead-beating for 1 min, centrifuged, and the supernatants collected and pooled. Protein concentrations were determined using the BCA microassay kit (Pierce) and 150 µg aliquots were frozen at 20 °C.
2D gel electrophoresis.
All equipment for IEF (Ettan IPGphor IEF unit) and 2D-PAGE (Ettan Dalt six electrophoresis unit) were purchased from Amersham Biosciences (GE Healthcare) except where indicated. Whole-cell protein extracts (150 µg) were incubated with 50 µl DNase/RNase solution [1 mg DNase I and 1 mg RNase A (Roche) ml1] for 1 h on ice. Proteins were concentrated by ultrafiltration at a molecular mass cut-off of 10 000 Da. Concentrated proteins were resuspended in 450 µl rehydration solution [8 M urea, 2 % (w/v) CHAPS, 0.5 % (v/v) carrier ampholytes, 0.002 % (w/v) bromophenol blue and 0.3 % (w/v) DTT] for 1 h at 4 °C and applied to 24 cm long immobilized pH 47 gradient (IPG) strips. The IPG strips were rehydrated overnight with the solubilized proteins (450 µl) at 20 °C under mineral oil. IEF followed rehydration for a total of 99.7 kVh at 20 °C. Focused strips were equilibrated in buffer [50 mM Tris/HCl, pH 8.8; 6 M urea; 30 % (v/v) glycerol; 2 % (w/v) SDS; 1 % (w/v) DTT] for 30 min then placed atop second dimension high-tensile-strength slab gels containing 12.5 % acrylamide (Duracryl, Genomic Solutions). Gels were electrophoresed overnight with a broad-range molecular mass marker (Bio-Rad) at 1.5 mA per gel and stained with silver nitrate (Rabilloud, 1999
; Shevchenko et al., 1996
). Protein spots were excised in a laminar flow hood with methanol-cleaned instruments and stored in 1 % acetic acid.
MALDI-TOF MS, liquid chromatography (LC)-MS/MS analysis and sequencing.
Protein spots excised from 2D-PAGE gels were sent for processing and analysis at the Genome BC Proteomics Centre at the University of Victoria, BC. In-gel digestion was performed with 400 ng modified porcine trypsin (Promega, #V5111) for 4 h at 37 °C. Peptides were extracted from the gel piece using 30 µl of 10 % (v/v) formic acid and spotted onto MALDI-TOF plates with
-cyano-4-hydroxycinnamic acid (CHCA) matrix using C18 ZipTips. The peptide mass data were submitted to MASCOT (http://www.matrixscience.com/search_form_select.html) for identification. Samples were further processed by LC-MS/MS if there were no confident search results. Samples were separated by one-dimensional (1D) reversed-phase chromatography using Analyst software (Applied Biosystems) controlled Ultimate gradient pumps, SwitchOS II and FAMOS Autosampler (LC Packings/Dionex) with a 75 µm i.d.x15 cm PepMap C18 3 µm, 100 Å nanocolumn (LC Packings/Dionex). Peptides were eluted and ionized by electrospray into a PE Sciex Qstar Pulsar I Quadrupole TOF MS. The MS/MS data obtained were submitted to ProID (proprietary Applied Biosystems software) for bioinformatics analysis of public protein databases (NCBI) and identification.
Western blotting.
Whole-cell and membrane proteins were separated by electrophoresis in a 12.5 % SDS-polyacrylamide gel and flagellin protein was detected by immunoblotting. The flagellin-specific rabbit polyclonal antiserum used was raised against purified Burkholderia pseudomallei flagellin and was a generous gift from Dr Don Woods (University of Calgary). Separated proteins were electroblotted onto PVDF membrane (Bio-Rad) for 1 h at 100 V. The membrane was rinsed with distilled water and with wash buffer [25 mM Tris; 137 mM NaCl, pH 7.5; 0.1 % (v/v) Tween 20] and then incubated in blocking buffer [wash buffer containing 5 % (w/v) BSA] for 1 h at room temperature. After incubation, the membrane was rinsed in wash buffer three times for 5 min then incubated overnight at 4 °C with the primary flagellin-specific antiserum at a dilution of 1 : 10 000 in blocking buffer. The membrane was rinsed again in wash buffer as above and incubated for 1 h at room temperature with secondary antibody [Phototope-horseradish peroxidase (HRP)-linked anti-rabbit immunoglobulin G; Cell Signalling] at a 1 : 2000 dilution in blocking buffer. Proteins were detected and developed using the HRP Western Blot Detection System (Cell Signalling), following the manufacturer's instructions. Protein standards included a prestained broad-range molecular mass marker (Bio-Rad) and the biotinylated protein ladder provided by the detection system (Cell Signaling).
PCR and RFLP analysis.
Flagellin (fliC) gene amplification with oligonucleotide primers BC4 (CTGGTCGCACAGCAGAACCTGAAC) and BCR12 (ACATGTTCGCGGTTTCCTG) was carried out as previously described (Hales et al., 1998
). Each reaction contained 40 ng genomic DNA template, 200 nM each primer, 100 µM dNTPs, 1xTaq buffer (Invitrogen), 2.5 mM MgCl2 and 2.5 U Taq polymerase (Invitrogen). PCR was performed for 30 cycles consisting of 1 min at 94 °C, 1 min at 56 °C and 2 min at 72 °C, followed by a final extension at 72 °C for 10 min. Flagellin gene PCR-amplified products (5 µl) were digested with restriction endonucleases HaeIII and MspI, or PstI as previously described (Hales et al., 1998
; Tungpradabkul et al., 1999
; Winstanley et al., 2001
). Reactions were carried out in volumes of 20 µl under the conditions recommended by the supplier (New England Biolabs).
Motility assays.
Motility was tested by spotting a single colony onto plates of LB adjusted to pH 7 and containing 0.3 % (w/v) agar. For acid induction of motility, LB was adjusted to pH 5. For high-salt effects on motility, LB was made with 0.5 or 1 M NaCl and adjusted to pH 7. Motility was assessed by measuring bacterial colony diameter following incubation at 37 °C for 48 h.
Oxidative stress assays.
Disc inhibition assays were used to test sensitivity to hydrogen peroxide and cumene hydroperoxide. Bacteria were grown in LB broth overnight and adjusted to 108 c.f.u. ml1 in LB broth. One millilitre of this bacterial suspension was added to 9 ml molten LB agar, mixed, and dispensed into Petri plates. Following solidification of agar, paper discs (6 mm) were soaked with 6 µl of 30 % (v/v) hydrogen peroxide or 15 µl of 10 % (w/v) cumene hydroperoxide and placed on the surface of agar plates. To test for sensitivity to reactive nitrogen intermediates (RNI), bacteria were grown in LB broth (pH 5) containing sodium nitrite for 16 h at 37 °C. Following incubation, cultures were diluted and plated onto LB agar quadrant plates for viable counts.
| RESULTS |
|---|
|
|
|---|
20 000 Da protein spot, C1. This spot was detected in C1394 but was not present in C1394mp2 (Fig. 1
|
|
|
|
45 000 Da band (arrow) that was more concentrated in the whole-cell protein extracts of C1394mp2 than in the parent C1394, suggesting enhanced expression of this protein in the former isolate. In addition, other bands below the 45 000 Da protein were highlighted with the antiserum in the whole-cell protein extracts of C1394mp2. It is possible that these bands correspond to the extra 2D-PAGE spots identified as flagellin (Fig. 3
|
|
45 000 Da band that was the most significant difference between the two isolates grown at 37 °C and was more prominent in the IM protein extracts of C1394mp2. The
45 000 Da band was excised, sequenced, and identified by LC-MS/MS, yielding the following amino acid sequence: INSAADDAAGLAISTR. This sequence matched with the BCC flagellin protein (accession no. gi4210944) and its enhanced expression in C1394mp2 correlates with the 2D proteome of C1394mp2. However, at 42 °C, C1394 and C1394mp2 appeared to have equivalent amounts of flagellin whereas at 37 °C, flagellin protein production was more apparent in C1394mp2 (Fig. 6a
|
| DISCUSSION |
|---|
|
|
|---|
Protein spot C1 was detected only in the C1394 proteome, and was identified as the AhpC protein of B. xenovorans. AhpC protein is among a number of antioxidant enzymes that are expressed by bacteria under oxidative stresses imposed by peroxides and RNI (Hofmann et al., 2002
; Springer et al., 2001
). Since proteins were extracted from stationary-phase cultures, AhpC expression in C1394 may have resulted from oxidative stresses encountered from metabolic respiration and oxygen depletion after exponential growth (McDougald et al., 2002
; Miller & Britigan, 1997
). The absence of AhpC protein in C1394mp2 did not affect viability but it correlated with reduced oxidative stress resistance. Compared to C1394, the variant was more susceptible to cumene hydroperoxide and acidified nitrite, the latter representing RNI. Although C1394mp2 showed a small increase in sensitivity to hydrogen peroxide, this result was reproduced over several assays. This small difference might be explained by compensatory activity by other oxidative protection enzymes such as catalase, which primarily detoxifies hydrogen peroxide. It is not clear how lack of AhpC expression would facilitate C1394mp2 persistence in a susceptible host. It is possible that AhpC may not have an active role in C1394mp2 persistence in the murine host. Interestingly, studies with Salmonella typhimurium showed that AhpC was a potential target for the immune system, eliciting an inflammatory response in animal hosts (Taylor et al., 1998
). Further studies are required to determine whether up-regulation of AhpC expression in B. cenocepacia results in rapid clearance from the murine host.
BCC flagellin appeared as three spots (M1 to M3) of different pIs in the proteome of C1394mp2, whereas only one protein spot (M2) was occasionally detected in C1394. SDS-PAGE of IM proteins and immunoblots confirmed that there was greater production of flagellin by C1394mp2 than by the parent, C1394. It is possible that the two additional 2D-PAGE spots (M1 and M3) and extra bands highlighted in immunoblots may represent modified or degraded forms of the flagellin produced by C1394mp2. Two of the three flagellin spots detected by 2D-PAGE (M1 and M2) had similar molecular masses yet possessed different pIs, a finding that may indicate post-translational modifications such as phosphorylation or glycosylation (Winstanley & Morgan, 1997
).
Environmental stimuli such as high salt concentrations impaired the growth and subsequently the motility of B. cenocepacia. However, an elevation in temperature resulted in increased flagellin production by C1394. Immunoblots detected more flagellin at 42 °C than at 37 °C, suggesting that flagellin production in B. cenocepacia is amplified in response to heat stress. Flagellin production was also affected at low pH, conditions under which both C1394 and C1394mp2 had enhanced motility. Although C1394 remained less motile than C1394mp2, its motility at pH 5 was comparable to that of C1394mp2 at neutral pH. This increase in motility at pH 5 may be due to the fact that low external pH generates a large pH difference across the inner cell membrane which contributes to the proton potential that powers motility (Maurer et al., 2005
). However, immunoblots also confirmed enhanced flagellin production in C1394 grown in acidic media. Growth on acidic LB agar did not induce the shiny phenotype in C1394, suggesting that flagellin production alone does not regulate the colonial morphology of B. cenocepacia. Nonetheless, these results implicate pH as a potentially important environmental signal that may regulate and enhance flagellin synthesis and motility in B. cenocepacia. This observation may provide some insight into B. cenocepacia survival in the CF host. The ASL in the CF lung is reported to be more acidic than normal ASL, a fact which may contribute to thicker than normal mucus, and affect the bactericidal activity of innate defences (Coakley et al., 2003
; Fischer et al., 2002
; Poschet et al., 2002
). Since increased flagellin production and motility are associated with the persistent phenotype of C1394mp2, these features may confer enhanced survival in an acidic environment such as the CF lung. Previous studies have also described the role of BCC flagella in in vitro host cell invasion as well as infectivity and inflammation in a mouse model, implicating its importance in BCC pathogenesis (Tomich et al., 2002
; Urban et al., 2004
).
In summary, our proteomic analyses identified AhpC and flagellin as candidate proteins to further characterize B. cenocepacia survival in the murine lung. Lack of AhpC expression in C1394mp2 correlates with susceptibility to oxidative stress; however, further investigation is required to identify its potential role in B. cenocepacia persistence. Flagellin production in B. cenocepacia appeared to be subject to environmental regulation as demonstrated in other pathogens that adapt to multiple conditions. The heat and acidic induction of flagellin production suggests that motility is amplified in response to stress and may facilitate adaptation and survival in hostile conditions, particularly within the host. Like pili and EPS, enhanced production of flagellin appears to be associated with B. cenocepacia survival in the murine host. Whilst protein expression under in vitro conditions may not necessarily reflect all proteins that are expressed in vivo, our study highlights differences that warrant further investigation into stress-regulated proteins that contribute to B. cenocepacia persistence.
| ACKNOWLEDGEMENTS |
|---|
Edited by: W. B. van Leeuwen
| REFERENCES |
|---|
|
|
|---|
Aris, R. M., Routh, J. C., LiPuma, J. J., Heath, D. G. & Gilligan, P. H. (2001). Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 164, 21022106.
Chen, L., Xie, Q. W. & Nathan, C. (1998). Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol Cell 1, 795805.[CrossRef][Medline]
Chernish, R. N. & Aaron, S. D. (2003). Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis. Curr Opin Pulm Med 9, 509515.[CrossRef][Medline]
Chu, K. K., Davidson, D. J., Halsey, T. K., Chung, J. W. & Speert, D. P. (2002). Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infect Immun 70, 27152720.
Chung, J. W., Altman, E., Beveridge, T. J. & Speert, D. P. (2003). Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infect Immun 71, 904909.
Coakley, R. D., Grubb, B. R., Paradiso, A. M., Gatzy, J. T., Johnson, L. G., Kreda, S. M., O'Neal, W. K. & Boucher, R. C. (2003). Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Natl Acad Sci U S A 100, 1608316088.
Fischer, H., Widdicombe, J. H. & Illek, B. (2002). Acid secretion and proton conductance in human airway epithelium. Am J Physiol Cell Physiol 282, C736C743.
Govan, J. R. & Deretic, V. (1996). Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60, 539574.
Govan, J. R., Hughes, J. E. & Vandamme, P. (1996). Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 45, 395407.
Hales, B. A., Morgan, J. A., Hart, C. A. & Winstanley, C. (1998). Variation in flagellin genes and proteins of Burkholderia cepacia. J Bacteriol 180, 11101118.
Hancock, R. E. & Nikaido, H. (1978). Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J Bacteriol 136, 381390.
Hofmann, B., Hecht, H. J. & Flohe, L. (2002). Peroxiredoxins. Biol Chem 383, 347364.[CrossRef][Medline]
Hutchison, M. L., Poxton, I. R. & Govan, J. R. (1998). Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun 66, 20332039.
LiPuma, J. J. (1998). Burkholderia cepacia. Management issues and new insights. Clin Chest Med 19, 473486, vi.[CrossRef][Medline]
Loprasert, S., Sallabhan, R., Whangsuk, W. & Mongkolsuk, S. (2003). Compensatory increase in ahpC gene expression and its role in protecting Burkholderia pseudomallei against reactive nitrogen intermediates. Arch Microbiol 180, 498502.[CrossRef][Medline]
Mahenthiralingam, E., Coenye, T., Chung, J. W., Speert, D. P., Govan, J. R., Taylor, P. & Vandamme, P. (2000). Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol 38, 910913.
Mahenthiralingam, E., Vandamme, P., Campbell, M. E., Henry, D. A., Gravelle, A. M., Wong, L. T., Davidson, A. G., Wilcox, P. G., Nakielna, B. & Speert, D. P. (2001). Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 33, 14691475.[CrossRef][Medline]
Mahenthiralingam, E., Baldwin, A. & Vandamme, P. (2002). Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol 51, 533538.
Mahenthiralingam, E., Urban, T. A. & Goldberg, J. B. (2005). The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3, 144156.[CrossRef][Medline]
Martin, D. W. & Mohr, C. D. (2000). Invasion and intracellular survival of Burkholderia cepacia. Infect Immun 68, 2429.
Maurer, L. M., Yohannes, E., Bondurant, S. S., Radmacher, M. & Slonczewski, J. L. (2005). pH regulates genes for flagellar motility, catabolism, and oxidative stress in Escherichia coli K-12. J Bacteriol 187, 304319.
McDougald, D., Gong, L., Srinivasan, S., Hild, E., Thompson, L., Takayama, K., Rice, S. A. & Kjelleberg, S. (2002). Defences against oxidative stress during starvation in bacteria. Antonie Van Leeuwenhoek 81, 313.[CrossRef][Medline]
Miller, R. A. & Britigan, B. E. (1997). Role of oxidants in microbial pathophysiology. Clin Microbiol Rev 10, 118.[Medline]
Poschet, J., Perkett, E. & Deretic, V. (2002). Hyperacidification in cystic fibrosis: links with lung disease and new prospects for treatment. Trends Mol Med 8, 512519.[CrossRef][Medline]
Rabilloud, T. (1999). Silver staining of 2-D electrophoresis gels. Methods Mol Biol 112, 297305.[Medline]
Sajjan, U. S., Sun, L., Goldstein, R. & Forstner, J. F. (1995). Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 177, 10301038.
Schwab, U., Leigh, M., Ribeiro, C., Yankaskas, J., Burns, K., Gilligan, P., Sokol, P. & Boucher, R. (2002). Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect Immun 70, 45474555.
Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. (1996). Mass spectrometric sequencing of proteins in silver-stained polyacrylamide gels. Anal Chem 68, 850858.[Medline]
Smith, J. J., Travis, S. M., Greenberg, E. P. & Welsh, M. J. (1996). Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229236.[CrossRef][Medline]
Sokol, P. A., Sajjan, U., Visser, M. B., Gingues, S., Forstner, J. & Kooi, C. (2003). The CepIR quorum-sensing system contributes to the virulence of Burkholderia cenocepacia respiratory infections. Microbiology 149, 36493658.
Speert, D. P., Henry, D., Vandamme, P., Corey, M. & Mahenthiralingam, E. (2002). Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 8, 181187.[Medline]
Springer, B., Master, S., Sander, P., Zahrt, T., McFalone, M., Song, J., Papavinasasundaram, K. G., Colston, M. J., Boettger, E. & Deretic, V. (2001). Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. Infect Immun 69, 59675973.
Taylor, P. D., Inchley, C. J. & Gallagher, M. P. (1998). The Salmonella typhimurium AhpC polypeptide is not essential for virulence in BALB/c mice but is recognized as an antigen during infection. Infect Immun 66, 32083217.
Tomich, M., Herfst, C. A., Golden, J. W. & Mohr, C. D. (2002). Role of flagella in host cell invasion by Burkholderia cepacia. Infect Immun 70, 17991806.
Tomich, M., Griffith, A., Herfst, C. A., Burns, J. L. & Mohr, C. D. (2003). Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun 71, 14051415.
Tungpradabkul, S., Wajanarogana, S., Tunpiboonsak, S. & Panyim, S. (1999). PCR-RFLP analysis of the flagellin sequences for identification of Burkholderia pseudomallei and Burkholderia cepacia from clinical isolates. Mol Cell Probes 13, 99105.[CrossRef][Medline]
Urban, T. A., Griffith, A., Torok, A. M., Smolkin, M. E., Burns, J. L. & Goldberg, J. B. (2004). Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infect Immun 72, 51265134.
Visser, M. B., Majumdar, S., Hani, E. & Sokol, P. A. (2004). Importance of the ornibactin and pyochelin siderophore transport systems in Burkholderia cenocepacia lung infections. Infect Immun 72, 28502857.
Winstanley, C. & Morgan, J. A. (1997). The bacterial flagellin gene as a biomarker for detection, population genetics and epidemiological analysis. Microbiology 143, 30713084.
Winstanley, C., Detsika, M. G., Glendinning, K. J., Parsons, Y. N. & Hart, C. A. (2001). Flagellin gene PCR-RFLP analysis of a panel of strains from the Burkholderia cepacia complex. J Med Microbiol 50, 728731.
Zabner, J., Smith, J. J., Karp, P. H., Widdicombe, J. H. & Welsh, M. J. (1998). Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell 2, 397403.[CrossRef][Medline]
Received 28 July 2006;
revised 2 October 2006;
accepted 9 October 2006.
This article has been cited by other articles:
![]() |
S. McClean and M. Callaghan Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention J. Med. Microbiol., January 1, 2009; 58(1): 1 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Soyza, A. Silipo, R. Lanzetta, J. R. Govan, and A. Molinaro Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides Innate Immunity, June 1, 2008; 14(3): 127 - 144. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |